QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
NASDAQ:EVFM

Evofem Biosciences Insider Trades

$0.41
-0.01 (-2.37%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.41
$0.44
50-Day Range
$0.37
$0.49
52-Week Range
$0.36
$5.53
Volume
1.42 million shs
Average Volume
6.43 million shs
Market Capitalization
$67.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.2

Evofem Biosciences (NASDAQ:EVFM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.90%

Number Of
Insiders Buying
(Last 12 Months)
5

Amount Of
Insider Buying
(Last 12 Months)
$195.43 K

Number Of
Insiders Selling
(Last 12 Months)
0

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get EVFM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Evofem Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Evofem Biosciences (NASDAQ EVFM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021Alexander A FitzpatrickGeneral CounselBuy25,000$0.39$9,750.00  
12/20/2021Justin J FileCFOBuy40,594$0.37$15,019.78  
12/20/2021Saundra L PelletierCEOBuy135,000$0.38$51,300.00  
6/18/2021Kim P KamdarDirectorBuy10,000$1.17$11,700.0019,287  
6/11/2021Russell BarransInsiderBuy18,180$1.14$20,725.20468,552  
6/10/2021Alexander A FitzpatrickGeneral CounselBuy10,000$1.02$10,200.00311,422  
6/10/2021Justin J FileCFOBuy24,500$1.03$25,235.00440,388  
6/10/2021Saundra L PelletierCEOBuy50,000$1.03$51,500.00850,837  
9/10/2020Russell BarransInsiderBuy1,000$2.71$2,710.00276,052  
9/8/2020Saundra L. PelletierCEOSell122,500$3.26$399,350.00  
6/17/2020Lisa Dale RarickDirectorBuy5,250$2.99$15,697.505,250  
6/15/2020William Walmsley HallDirectorBuy5,000$2.85$14,250.005,000  
6/12/2020Justin J. FileCFOBuy8,500$3.14$26,690.00  
6/12/2020Kim P KamdarDirectorBuy5,000$2.94$14,700.009,287  
6/5/2020Ltd. InvescoMajor ShareholderBuy857,143$3.45$2,957,143.351,000  
5/26/2020Ltd. InvescoMajor ShareholderSell73,879$5.79$427,759.41  
5/15/2020Ltd. InvescoMajor ShareholderSell3,211$5.04$16,183.44  
4/30/2020Kelly CulwellInsiderSell1,000$4.66$4,660.00195,226  
1/16/2020Russell BarransInsiderSell1,578$6.50$10,257.00196,298  
1/13/2020Justin J FileCFOSell1,648$6.00$9,888.00177,251  
1/13/2020Saundra L PelletierCEOSell3,295$6.00$19,770.00362,289  
1/2/2020Justin J FileCFOSell3,352$6.05$20,279.60178,899  
1/2/2020Saundra L PelletierCEOSell6,705$6.05$40,565.25365,584  
12/2/2019Justin J FileCFOSell10,000$7.16$71,600.00182,251  
12/2/2019Kelly CulwellInsiderSell1,000$7.35$7,350.0043,538  
12/2/2019Saundra L PelletierCEOSell20,000$7.30$146,000.00372,289  
11/21/2019Saundra L PelletierCEOSell10,000$6.01$60,100.00424,676  
11/20/2019Justin J FileCFOSell100$6.00$600.00207,353  
6/10/2019Pdl Biopharma, Inc.Major ShareholderBuy6,666,667$4.50$30,000,001.50  
5/21/2019Kim P KamdarDirectorSell655$5.07$3,320.85  
2/8/2019Ltd. InvescoMajor ShareholderBuy425,531$2.64$1,123,401.84  
11/21/2018Russell BarransInsiderBuy279$3.55$990.45  
8/21/2018Alexander A FitzpatrickGeneral CounselBuy5,000$2.21$11,050.00  
8/16/2018Kelly CulwellInsiderBuy3,000$2.24$6,720.00  
8/15/2018Thomas G LynchDirectorBuy100,000$2.26$226,000.00  
8/10/2018Russell BarransInsiderBuy3,715$1.98$7,355.70  
8/10/2018Saundra L PelletierCEOBuy10,000$2.11$21,100.00  
5/22/2018Ltd. InvescoMajor ShareholderBuy2,127,659$4.69$9,978,720.71  
12/30/2015Alta Partners Viii, L.P.InsiderSell797,987$1.51$1,204,960.37  
12/29/2015Alta Partners Viii, L.P.Major ShareholderSell493,654$1.53$755,290.62  
12/28/2015Alta Partners Viii, L.P.Major ShareholderSell54,333$1.59$86,389.47  
12/17/2015Kenneth W. LockeInsiderSell598$1.26$753.48  
12/17/2015Susan A. KnudsonCFOSell1,005$1.26$1,266.30  
12/15/2015Alta Partners Viii, L.P.Major ShareholderSell529,261$1.44$762,135.84  
11/18/2015Kenneth W. LockeinsiderSell6,098$8.30$50,613.40293  
9/18/2015Christopher KemmererVPSell1,000$12.20$12,200.0010,848  
9/1/2015Susan A. KnudsonCFOSell3,000$11.33$33,990.00492  
3/19/2015George W MahaffeyCEOBuy1,000$7.76$7,760.00  
11/25/2014Daniel JanneyDirectorSell149,286$14.00$2,090,004.00  
11/25/2014Rmi Investments S.A.R.L.Major ShareholderBuy70,000$14.00$980,000.00  
(Data available from 1/1/2013 forward)












Evofem Biosciences (NASDAQ:EVFM) Insider Trade Frequently Asked Questions

Who is on Evofem Biosciences's Insider Roster?

The list of insiders at Evofem Biosciences includes Alexander A Fitzpatrick, Justin J File, Kelly Culwell, Kim P Kamdar, Lisa Dale Rarick, Ltd. Invesco, Pdl Biopharma, Inc., Russell Barrans, Saundra L Pelletier, and William Walmsley Hall.Learn more on EVFM's insiders

What percentage of Evofem Biosciences stock is owned by insiders?

3.90% of Evofem Biosciences stock is owned by insiders. Learn more on EVFM's insider holdings

Which Evofem Biosciences insiders have been buying company stock?

The following insiders have purchased Evofem Biosciences stock in the last 24 months: Alexander A Fitzpatrick ($19,950.00), Justin J File ($40,254.78), Kim P Kamdar ($26,400.00), Lisa Dale Rarick ($15,697.50), Ltd. Invesco ($2,957,143.35), Russell Barrans ($23,435.20), Saundra L Pelletier ($102,800.00), and William Walmsley Hall ($14,250.00).

How much insider buying is happening at Evofem Biosciences?

Insiders have purchased a total of 1,195,167 Evofem Biosciences shares in the last 24 months for a total of $3,226,620.83 bought.

Which Evofem Biosciences insiders have been selling company stock?

The following insiders have sold Evofem Biosciences stock in the last 24 months: Kelly Culwell ($4,660.00), Ltd. Invesco ($443,942.85), and Saundra L. Pelletier ($399,350.00).

How much insider selling is happening at Evofem Biosciences?

Insiders have sold a total of 200,590 Evofem Biosciences shares in the last 24 months for a total of $847,952.85 sold.

This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.